| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5581723 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 6 Pages |
Abstract
Compared with fosaprepitant, olanzapine reduced the number of patients with acute (PÂ < .0318) and delayed (PÂ < .1519) nausea and reduced the need for rescue medications for acute-onset (PÂ < .0643) and delayed-onset (PÂ < .0024) CINV.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Steven Trifilio, Colleen Welles, Kristin Seeger, Shivani Mehta, MaryAnne Fishman, Katherine McGowan, Kathryn Strejcek, Emily Eiten, Carolyn Pirotte, Elizabeth Lucier, Sean DeFrates, Jayesh Mehta,